Breast cancer is the most common tumor in women.
1,2 While the incidence among black and white women in the United States has converged at 135 cases per 100 000 women per year in recent years, the mortality gap has continued to increase, with a 42% higher death rate in black patients.
3 The reasons for this survival gap are multifactorial and may include access to care and inherent biological tumor differences.
4 One known biological cause of this racial disparity is the higher frequency of basal-like or triple-negative breast cancers (TNBCs) (ie, negative for estrogen receptor [ER], progesterone receptor, and human epidermal growth factor receptor 2 [ERBB2, formerly HER2]) among black women.
5-10 However, there is a paucity of data on additional biological or genomic differences that explain the higher mortality rate in blacks. Increased genetic predisposition due to higher risk allele frequencies at the
TERT (OMIM 187270) locus and a higher prevalence of specific lifestyle factors, such as lack of breastfeeding, may contribute to intrinsic subtype frequency differences seen across ethnicities.
11,12